跳至主要内容
临床试验/TCTR20190802001
TCTR20190802001招募中未知

The effectiveness of Combined oral contraceptive pills(COC) in prevention of persistent corpus luteal cyst after oocyte retrieval in in vitro fertilization(IVF) technique, A randomized control trial

Mahidol university0 个研究点目标入组 130 人开始时间: 2019年8月2日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
130

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
Female

入选标准

  • 1. Female patients at Infertility Unit who have indications for in vitro fertilization.
  • 2. IVF using embryo cryopreservation according to the opinion of the obstetrician or have indications such as
  • - Have more than 20 oocytes.
  • - Endometrium has an inappropriate condition for embryo transfer.
  • - Genetic diagnosis is needed before embryo transfer
  • 3. Women aged 18-45 years.
  • 4. Those who volunteered to participate in research projects.

排除标准

  • 1. Contraindications of combined oral contraceptive pills include:
  • a. Women with history of abnormalities in the circulatory system especially the abnormalities related to thrombosis, deep vein thrombosis, pulmonary embolism, coronary heart disease or at other parts of the body.
  • b. Women with history of stroke.
  • c. Symptoms that are suspected to be myocardial infarction or cerebrovascular disease.
  • d. Migraine with symptoms such as vision disorders, aphasia and motor weakness.
  • e. Diabetes with vascular complications.
  • f. Pancreatitis related to high blood cholesterol.
  • g. Jaundice or severe liver disease
  • h. Cancer that may be stimulated by sex hormones such as breast cancer or genital organ cancer.
  • i. Liver tumor both mild and severe types.
  • j. Undiagnosed abnormal vaginal bleeding
  • k. Allergic to ethinyl estradiol or desogestrel
  • l. Smoker over the age of 35.
  • 2. Ovarian cysts occur before the IVF process.

研究者

相似试验